rs796065024
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM2PM4PP3PP5_Very_Strong
The NM_199242.3(UNC13D):βc.1828_1839delβ(p.Arg610_Gln613del) variant causes a inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,459,948 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β β ). Synonymous variant affecting the same amino acid position (i.e. R610R) has been classified as Likely benign.
Frequency
Consequence
NM_199242.3 inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UNC13D | NM_199242.3 | c.1828_1839del | p.Arg610_Gln613del | inframe_deletion | 20/32 | ENST00000207549.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UNC13D | ENST00000207549.9 | c.1828_1839del | p.Arg610_Gln613del | inframe_deletion | 20/32 | 1 | NM_199242.3 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1459948Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 726260
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Familial hemophagocytic lymphohistiocytosis 3 Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Mar 22, 2022 | .Inframe deletion located in a nonrepeat region: predicted to change the length of the protein and disrupt normal protein function. Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product (PMID: 14622600). This variant has been reported as pathogenic (ClinVar ID: VCV000001996, PMID:14622600)It is not observed in the gnomAD v2.1.1 dataset. Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 2006 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Oct 09, 2022 | This variant, c.1828_1839del, results in the deletion of 4 amino acid(s) of the UNC13D protein (p.Arg610_Gln613del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with hemophagocytic lymphohistiocytosis (PMID: 14622600, 16825436, 27914778). It has also been observed to segregate with disease in related individuals. This variant is also known as Munc13-4 1822 del 12 bp (Del V608-A611). ClinVar contains an entry for this variant (Variation ID: 1996). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects UNC13D function (PMID: 14622600, 15548590, 21182842). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at